Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: August 23, 2022
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 12, 2015
The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.
Journal: PloS one
Published: July 23, 2012
Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesia.
Journal: Journal of cardiovascular pharmacology
Published: December 20, 2011
Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitors.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 01, 2011
Showing 1-5 of 5
Last Updated: 09/26/2026